Our mission: To reduce the burden of cardiovascular disease.Need help?
An active group involved in important aspect of most disciplines within cardiology with all aspects of cardiovascular pharmacology, from basic pharmacology over clinical trials to clinical pharmacology.
Access the resources from training courses and register for upcoming events.
Access a selection of valuable scientific articles and position papers.
New group dedicated to young professionals under 40 with a special interest in cardiovascular pharmacotherapy and clinical trials.
This “talk show” format event is to underline the main cardio-reno-metabolic protective effects of SGLT2i, the mechanism and the limits of our knowledge.
Learning objectives:
- Understand and interpret the specific clinical benefit and safety of SGLT2i
- Understand the subtle mechanisms of action
- Understand the limits of knowledge and future directions of research
The spotlight will be 'Global Health', as we explore cardiology beyond borders, highlighting the shifting role of cardiovascular disease within the broader global health landscape.
Madrid - Spain European Society of Cardiology congress@escardio.org true DD/MM/YYYY
European Society of Cardiology
European Heart House
Les Templiers
2035 Route des Colles
CS 80179 Biot
06903, Sophia Antipolis, France